Patents-Review.com
ClassID:

20940 ⎘

A61K38/178 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants Lectin superfamily, e.g. selectins

Recent Application in this class:
#1
20260139030
2026-05-21

CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION

 #2
20260069530
2026-03-12

METHODS OF TREATING PRIMARY LIVER TUMORS WITH NATURAL KILLER CELLS EXPRESSING A CYTOTOXIC RECEPTOR COMPLEX

 #3
20250319024
2025-10-16

TARGETED NANOPARTICLES AND THEIR USES RELATED TO INFECTIOUS DISEASE

 #4
20250244326
2025-07-31

BLOOD BIOMARKERS IN LONG-COVID-19

 #5
20250152668
2025-05-15

PROTEIN FOR TREATMENT OF INFLAMMATORY DISEASES

 #6
20240398899
2024-12-05

LECTIN PROTEIN FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES

 #7
20240325450
2024-10-03

NKT-CELL SUBSET FOR IN VIVO PERSISTENCE AND THERAPEUTIC ACTIVITY AND PROPAGATION OF SAME

 #8
20240238372
2024-07-18

HIP/PAP PROTEIN OR A DERIVATIVE THEREOF FOR TREATING PERIPHERAL NEUROPATHY

 #9
20240190942
2024-06-13

NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY

 #10
20240165201
2024-05-23

GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN MUSCLE DISEASES AND AUTOIMMUNE DISORDERS

 #11
20240123029
2024-04-18

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS

 #12
20230310510
2023-10-05

FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION

 #13
20230053285
2023-02-16

GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF

 #14
20230037076
2023-02-02

CHIMERIC CHLOROTOXIN RECEPTORS

 #15
20220378696
2022-12-01

TARGET DELIVERY OF NON-BIOLOGICS THROUGH NANOTECHNOLOGY FOR TISSUE REPAIR

 #16
20220348872
2022-11-03

CHIMERIC ANTIGEN RECEPTOR ANTI-INFLAMMATORY CELLS AND METHODS OF USE

 #17
20220125878
2022-04-28

Compositions and Methods for Preventing the Interaction Between SARS-COV-2 and L-Sign

 #18
20220047671
2022-02-17

PROTEIN FOR TREATMENT OF INFLAMMATORY DISEASES

 #19
20220008476
2022-01-13

Genetically engineered hematopoietic stem cells and uses thereof

 #20
20210386820
2021-12-16

ANTIVIRAL LECTIN AND USES THEREOF

 #21
20210338727
2021-11-04

NATURAL KILLER CELL COMPOSITIONS AND IMMUNOTHERAPY METHODS FOR TREATING TUMORS

 #22
20210322513
2021-10-21

METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER

 #23
20210317414
2021-10-14

Methods for mobilizing stem cells

 #24
20210315936
2021-10-14

Genetically engineered hematopoietic stem cells and uses thereof

 #25
20210236559
2021-08-05

Genetically engineered hematopoietic stem cells and uses thereof

 #26
20210228641
2021-07-29

Genetically engineered hematopoietic stem cells and uses thereof

 #27
20210220407
2021-07-22

Genetically engineered hematopoietic stem cells and uses thereof

 #28
20210130434
2021-05-06

NKG2D-IG fusion protein for cancer immunotherapy

 #29
20210060158
2021-03-04

AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY

 #30
20200338130
2020-10-29

Genetically engineered hematopoietic stem cells and uses thereof

 #31
20200318071
2020-10-08

Genetically engineered hematopoietic stem cells and uses thereof

 #32
20200163992
2020-05-28

NKT-cell subset for in vivo persistence and therapeutic activity and propagation of same

 #33
20200138869
2020-05-07

Genetically engineered hematopoietic stem cells and uses thereof

 #34
20200129591
2020-04-30

Composition having tissue-repairing activity, and use therefor

 #35
20200093865
2020-03-26

Genetically engineered hematopoietic stem cells and uses thereof

 #36
20200055909
2020-02-20

Chimeric chlorotoxin receptors

 #37
20200046780
2020-02-13

FasL-engineered biomaterials with immunomodulatory function

 #38
20200009225
2020-01-09

METHOD TO FUNCTIONALIZE CELLS IN HUMAN BLOOD, OTHER FLUIDS AND TISSUES USING NANOPARTICLES

 #39
20190316153
2019-10-17

Packaging cell for making a pseudotyped lentivirus

 #40
20190247460
2019-08-15

Cell modulation

 #41
20190216975
2019-07-18

Hemostatic material, preparation method thereof and pharmaceutical composition containing the same

 #42
20190185532
2019-06-20

INHIBITORS

 #43
20190167763
2019-06-06

TOPICAL PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH AND/OR REDUCING HAIR LOSS

 #44
20180355013
2018-12-13

NKG2D-IG fusion protein for cancer immunotherapy

 #45
20180311313
2018-11-01

Composition having tissue-repairing activity, and use therefor

 #46
20180265846
2018-09-20

Chimeric antigen receptor anti-inflammatory cells and methods of use

 #47
20180264040
2018-09-20

NKT-cell subset for in vivo persistence and therapeutic activity and propagation of same

 #48
20180250360
2018-09-06

METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER

 #49
20180193415
2018-07-12

Methods and agents for treating Alzheimer's disease

 #50
20180179555
2018-06-28

Methods of delivering a pseudotyped lentivirus

 #51
20160340692
2016-11-24

Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein

 #52
20160310532
2016-10-27

NKT-cell subset for in vivo persistence and therapeutic activity and propagation of same

 #53
20160280751
2016-09-29

COMPOUNDS AND METHODS FOR TREATMENT OR PREVENTION OF A PATHOGEN INFECTION

 #54
20160207968
2016-07-21

Targeting of podoplanin with lectin for use in the prevention and treatment of cancer

 #55
20160184395
2016-06-30

Method to functionalize cells in human blood, other fluids and tissues using nanoparticles

 #56
20160175394
2016-06-23

Compositions and uses of lectins

 #57
20160074539
2016-03-17

Targeting constructs

 #58
20160038566
2016-02-11

Methods and agents for treating Alzheimer's disease

 #59
20150352187
2015-12-10

Composition having tissue-repairing activity, and use therefor

 #60
20150175667
2015-06-25

Method of stimulating an immune response using a pseudotyped lentivirus

 #61
20140256613
2014-09-11

PEPTIDE COMPOSITIONS THAT DOWNREGULATE TLR-4 SIGNALING PATHWAY AND METHODS OF PRODUCING AND USING SAME

 #62
20140155470
2014-06-05

PLA2R1 AS ANTI-TUMORAL COMPOUND AND AS BIOMARKER FOR THE DETECTION OF CANCER

 #63
20140093475
2014-04-03

Suppression of bone loss by introducing FoxP3+ CD8 T-cells (Tc)

 #64
20140057858
2014-02-27

Methods for increasing the embryo implantation rate in mammals

 #65
20130072423
2013-03-21

CD44V6 peptides as inhibitors of bacterial infections

 #66
20130045924
2013-02-21

Methods of reducing hypoxic stress in a mammal by administering soluble P-selectin

 #67
20130029912
2013-01-31

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis

 #68
20120328568
2012-12-27

COMPOSITIONS AND USES OF LECTINS

 #69
20120070462
2012-03-22

Targeted gene delivery to dendritic cells

 #70
20120010152
2012-01-12

Targeting of podoplanin with lectin for use in the prevention and treatment of cancer

 #71
20110020270
2011-01-27

Compositions comprising E-selectin antagonists and uses therefor

 #72
20110002881
2011-01-06

Treatment of immunocompromised conditions

 #73
20100305026
2010-12-02

CD44V6 peptides as inhibitors of bacterial infections

 #74
20100166649
2010-07-01

Method to inhibit cancer targeting CD24

 #75
20100120140
2010-05-13

Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN

 #76
20100120122
2010-05-13

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

 #77
20100104585
2010-04-29

Methods and Reagents for Regulation of Cellular Responses in Biological Systems

 #78
20090285839
2009-11-19

Antigen uptake receptor for candida albicans on dendritic cells

 #79
20090208488
2009-08-20

Regulation of dendritic cell functions by the DCAL-2 receptor

 #80
20090074756
2009-03-19

USE OF LLT1 AND/OR CD161 FOR MODULATTING THE ACTIVITY OF CELLS OF THE IMMUNE SYSTEM

 #81
20080193949
2008-08-14

METHODS FOR DIAGNOSING AND TREATING HEMOSTATIC DISORDERS BY MODULATING P-SELECTIN ACTIVITY

 #82
20080175916
2008-07-24

Vessel enlargement by arteriogenic factor delivery

 #83
20080070830
2008-03-20

Homing of cells to myocardium

 #84
20080019998
2008-01-24

Targeted gene delivery for dendritic cell vaccination

 #85
20070270351
2007-11-22

Methods and Reagents for Regulation of Cellular Responses in Biological Systems

 #86
20070253975
2007-11-01

Methods for preventing strokes by inducing tolerance to E-selectin

 #87
20060233805
2006-10-19

Antigen uptake receptor for on dendritic cells

 #88
20060171929
2006-08-03

Regulation of dendritic cell functions by the DCAL-2 receptor

 #89
20060002892
2006-01-05

Methods for increasing production of IFN-gamma in natural killer cells expressing LLT1 receptor

 #90
20050202007
2005-09-15

Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity

 #91
20050137126
2005-06-23

Treatment of SARS in individuals

 #92
20050059582
2005-03-17

Use of soluble P-selectin and anthrax lethal toxin

 #93
13037996
2023-12-26

Method and apparatus for ultrasonic delivery of drugs and contrast agents